摘要
目的评价高龄糖尿病并慢性肾脏病患者采用前列地尔治疗的安全性、有效性。方法便利抽取2013年6月—2016年6月该院收治的高龄糖尿病并慢性肾脏病62例患者,采用抽签法分为对照组和研究组,对照组30例,采用常规治疗,研究组32例,在常规治疗基础上使用前列地尔,评价两组患者的治疗情况。结果研究组治疗后的尿酸、血肌酐、尿素均低于对照组,两组比较差异有统计学意义(P<0.05),在不良反应发生率上,两组比较差异无统计学意义(P>0.05)。结论高龄糖尿病并慢性肾脏病患者使用前列地尔治理,临床效果显著,安全性高,具有推广和应用的价值。
Objective To evaluate the safety and effectiveness of alprostadil in treatment of senile diabetes combined with chronic renal disease. Methods 62 cases of senile patients with diabetes combined with chronic renal diseases admitted and treated in our hospital from June 2013 to June 2016 were convenient selected and randomly divided into two groups, the control group with 30 cases used the routine therapy, while the research group with 32 cases used the alprostadil on the basis of the control group, and the treatment conditions of the two groups were evaluated. Results After treatment, the uric acid, blood creatinine, urea in the research group were lower than those in the control group, and the differences between groups were obvious（P〈0.05）, and the difference in the incidence rate of adverse reactions between the two groups was not statistically significant（P〉0.05）. Conclusion The clinical effect of alprostadil in treatment of senile diabetes combined with chronic renal disease is obvious with high safety, which is of promotion and application value.
作者
林树棣
LIN Shu-di(People＇s Hospital of Red Bay Economic Development Zone,Shanwei,Guangdong Province,516622 China)
出处
《中外医疗》
2018年第11期127-128,共2页
China & Foreign Medical Treatment
